-
- Breast Cancer
Palbonix 125mg & 100mg (Palbociclib): New breast cancer treatment
- Palbonix (Palbociclib) is a targeted therapy that has revolutionized the treatment of new breast cancer treatment. Available in 125mg and 100mg doses, Palbonix helps manage hormone receptor-positive and HER2-negative metastatic new breast cancer treatment. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK 4/6), crucial proteins involved in cell division, slowing down the growth of cancer cells.
- Read more
